Seegene, stock price down 2.34% at this hour... 'Seegene's estimates are becoming more realistic through adjustments in diagnostic kit exports'

As of 10:33 AM on the 3rd, Seegene is trading at 108,600 KRW, down 2.34% from the previous day. The trading volume is 806,873 shares, which is about 39.07% of the previous day's volume. Seegene is known as a developer, manufacturer, and seller of molecular diagnostic reagents.

On June 3rd, Minjeong Seon, a researcher at Hana Financial Investment, stated, "As governments around the world are expected to stockpile COVID-19 diagnostic kits, exports of COVID-19 diagnostic kits are also expected to exceed second-quarter export amounts in the second half of this year. From the second half of 2022, as the COVID-19 virus pandemic subsides, COVID-19 diagnostic kits are expected to contract by about 30% compared to the previous year. However, as Seegene's equipment is installed to some extent in clinical pathology centers, the overall growth of Seegene's other reagent sales is expected to maintain a significant upward trend." She set Seegene's target price at 150,000 KRW.

Over the past five days, individual investors have net purchased 464,581 shares of Seegene, while foreigners and institutions have net sold 335,084 shares and 128,352 shares, respectively.

※Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.

This content was produced with the assistance of AI translation services.